-
. However, progress is constrained by the scarcity of high-quality, well-characterized in vitro T-cell immunogenicity data. In this project, we will leverage expertise and technology in peptide T-cell
-
have developed a range of genetic engineering strategies to modify EVs for the purpose of drug delivery. In addition to EVs, the EL Andaloussi lab also engineers various conjugates for extrahepatic
Enter an email to receive alerts for quantum-engineering-"https:"-"https:" positions